KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease
- PMID: 34906417
- PMCID: PMC9354805
- DOI: 10.1016/j.kint.2021.11.020
KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease
Comment in
-
The authors reply.Kidney Int. 2022 Feb;101(2):420-421. doi: 10.1016/j.kint.2021.11.019. Epub 2021 Dec 11. Kidney Int. 2022. PMID: 34906418 No abstract available.
Comment on
-
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019. Kidney Int. 2020. PMID: 32998798 No abstract available.
References
-
- Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2020;98(4S):S1–S115. - PubMed
-
- Okada T, Nakao T, Matsumoto H, et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 2011;50:23–29. - PubMed
-
- Copur S, Siriopol D, Afsar B, et al. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker. Acta Diabetol 2021;58:81–91. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
